RYGB与袖状胃切除术在不同种族中的安全性与有效性比较:PCORnet减重研究队列
RYGB在各组减重和HbA1c降幅均优于SG但差异幅度小;Black和Hispanic患者RYGB较SG住院风险更高,Hispanic患者RYGB的全因死亡和30天主要不良事件风险更高。
要点
- RYGB在Black、Hispanic、White患者中5年减重和HbA1c降幅均优于SG但差异幅度小。
- Black和Hispanic患者RYGB较SG住院风险更高。
- Hispanic患者RYGB较SG全因死亡和30天主要不良事件风险更高。
核心结论
- RYGB与SG在%TWL和HbA1c上的比较效果随种族和族裔的变异性在临床上很小。
- Black和Hispanic患者接受RYGB较SG的安全性和利用结局差异具有临床和统计学显著性。
研究设计与样本
- 回顾性观察性比较效果队列研究,纳入PCORnet减重研究中25个医疗系统。
- 纳入2005年1月1日至2015年9月30日接受初次RYGB或SG的12至79岁患者。
主要发现
- Black、Hispanic和White患者中RYGB在各年份的减重和HbA1c平均降幅均大于SG。
- 5年减重差异:Black -7.6%(95%CI -8.0至-7.1,P<.001);Hispanic -6.2%(95%CI -6.6至-5.9,P<.001);White -5.9%(95%CI -6.3至-5.7,P<.001)。
- 第5年HbA1c变化差异:Black -0.29(95%CI -0.51至-0.08,P=.009);Hispanic -0.45(95%CI -0.61至-0.29,P<.001);White -0.25(95%CI -0.40至-0.11,P=.001)。
- Black和Hispanic患者RYGB较SG住院风险更高:HR分别为1.45(95%CI 1.17-1.79,P=.001)和1.48(95%CI 1.22-1.79,P<.001)。
- Hispanic患者RYGB较SG全因死亡风险更高(HR 2.41,95%CI 1.24-4.70,P=.01),30天主要不良事件比值比更高(OR 1.92,95%CI 1.38-2.68,P<.001)。
关键数值与推荐
- RYGB与SG在%TWL和HbA1c上的差异幅度在不同种族和族裔间为1%-3%的%TWL。
- 种族和族裔与手术类型在糖尿病缓解和复发上无交互作用。
临床怎么用
- 研究结果可用于不同种族和族裔患者减重手术方式选择的共享决策。
- 对Black和Hispanic患者选择RYGB时应权衡其较SG更高的住院及不良事件风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Bariatric surgery is the most effective treatment for severe obesity; yet it is unclear whether the long-term safety and comparative effectiveness of these operations differ across racial and ethnic groups. OBJECTIVE: To compare outcomes of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) across racial and ethnic groups in the National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective, observational, comparative effectiveness cohort study that comprised 25 health care systems in the PCORnet Bariatric Study. Patients were adults and adolescents aged 12 to 79 years who underwent a primary (first nonrevisional) RYGB or SG operation between January 1, 2005, and September 30, 2015, at participating health systems. Patient race and ethnicity included Black, Hispanic, White, other, and unrecorded. Data were analyzed from July 1, 2021, to January 17, 2022. EXPOSURE: RYGB or SG. OUTCOMES: Percentage total weight loss (%TWL); type 2 diabetes remission, relapse, and change in hemoglobin A1c (HbA1c) level; and postsurgical safety and utilization outcomes (operations, interventions, revisions/conversions, endoscopy, hospitalizations, mortality, 30-day major adverse events) at 1, 3, and 5 years after surgery. RESULTS: A total of 36 871 patients (mean [SE] age, 45.0 [11.7] years; 29 746 female patients [81%]) were included in the weight analysis. Patients identified with the following race and ethnic categories: 6891 Black (19%), 8756 Hispanic (24%), 19 645 White (53%), 826 other (2%), and 783 unrecorded (2%). Weight loss and mean reductions in HbA1c level were larger for RYGB than SG in all years for Black, Hispanic, and White patients (difference in 5-year weight loss: Black, -7.6%; 95% CI, -8.0 to -7.1; P < .001; Hispanic, -6.2%; 95% CI, -6.6 to -5.9; P < .001; White, -5.9%; 95% CI, -6.3 to -5.7; P < .001; difference in change in year 5 HbA1c level: Black, -0.29; 95% CI, -0.51 to -0.08; P = .009; Hispanic, -0.45; 95% CI, -0.61 to -0.29; P < .001; and White, -0.25; 95% CI, -0.40 to -0.11; P = .001.) The magnitude of these differences was small among racial and ethnic groups (1%-3% of %TWL). Black and Hispanic patients had higher risk of hospitalization when they had RYGB compared with SG (hazard ratio [HR], 1.45; 95% CI, 1.17-1.79; P = .001 and 1.48; 95% CI, 1.22-1.79; P < .001, respectively). Hispanic patients had greater risk of all-cause mortality (HR, 2.41; 95% CI, 1.24-4.70; P = .01) and higher odds of a 30-day major adverse event (odds ratio, 1.92; 95% CI, 1.38-2.68; P < .001) for RYGB compared with SG. There was no interaction between race and ethnicity and operation type for diabetes remission and relapse. CONCLUSIONS AND RELEVANCE: Variability of the comparative effectiveness of operations for %TWL and HbA1c level across race and ethnicity was clinically small; however, differences in safety and utilization outcomes were clinically and statistically significant for Black and Hispanic patients who had RYGB compared with SG. These findings can inform shared decision-making regarding bariatric operation choice for different racial and ethnic groups of patients.
引用
- Coleman KJ, Wellman R, Fitzpatrick SL, et al. Comparative Safety and Effectiveness of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for Weight Loss and Type 2 Diabetes Across Race and Ethnicity in the PCORnet Bariatric Study Cohort. JAMA Surg. 2022. PMID: 36044239. doi:10.1001/jamasurg.2022.3714
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。